- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Deutsch
- Erschienen in
-
Aktivierung natürlicher Killerzellen zur Behandlung von Tumorerkrankungen ; volume:29 ; number:6 ; day:19 ; month:10 ; year:2023 ; pages:603-605 ; date:10.2023
Biospektrum ; 29, Heft 6 (19.10.2023), 603-605, 10.2023
- Schlagwort
-
Natürliche Killerzelle
Krebs
Immuntherapie
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12268-023-2022-8
- URN
-
urn:nbn:de:101:1-2024010810093671734384
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Harwardt, Julia
- Schoenfeld, Katrin
- Kolmar, Harald
- SpringerLink (Online service)
Ähnliche Objekte (12)
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Toward a robust lipid supplementation for SP2/0 fed-batch culture: Improving process performance by leveraging lipoprotein variability